Payne Fletcher 4
4 · Aptose Biosciences Inc. · Filed Jun 28, 2022
Insider Transaction Report
Form 4
Payne Fletcher
SR VP & Chief Fin. Officer
Transactions
- Award
Common Stock
2022-06-27+1,000,000→ 1,000,000 totalExercise: $0.85Exp: 2032-06-26→ Common Stock (1,000,000 underlying)
Footnotes (1)
- [F1]The options vest as follows: 50% of the options vest on 6/27/2023; the remaining options will vest in equal annual installments on June 27, 2024, June 27, 2025, and June 27, 2026.